ArticleDrug delivery and translational research2026
About the impact of medium chain fatty acids on the permeation enhancing effects of self-emulsifying drug delivery systems.
Article in Drug delivery and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Self-emulsifying drug delivery systems (SEDDS) are widely utilized to enhance oral drug absorption; however, limited epithelial permeability remains a major barrier, particularly for hydrophilic drugs and macromolecules. Medium-chain fatty acids are promising permeation enhancers (PEs) due to their transient effects on epithelial barriers. In this study, caprylic acid (C8) and capric acid (C10) were systematically evaluated as PEs in SEDDS, with emphasis on the influence of ionization state and mode of presentation within the formulation. SEDDS were modified by incorporating C8 or C10 either as free acids (SEDDS-C8/C10@Acid), as dispersed sodium salts (SEDDS-C8/C10@Salt), or by external addition of sodium salts after emulsification (SEDDS-C8/C10@extSalt). SEDDS-C8/C10@Acid significantly enhanced cellular internalization in Caco-2, HEK, and HeLa cells, achieving up to a 2.5-fold increase compared with unmodified SEDDS. In contrast, salt-based systems showed approximately 1.5-fold lower cellular association than acid formulations, while exhibiting improved cellular tolerability. Permeation studies revealed pronounced epithelial permeation across Caco-2 monolayers for salt-modified SEDDS, with lucifer yellow permeation increasing up to 7-fold for both C8 and C10 systems. Consistently, mucus interaction studies demonstrated enhanced diffusion for salt-based formulations. Differences between C8- and C10-containing systems were minor, indicating that alkyl chain length was less influential than ionization state and formulation format. Overall, incorporation of the free acid PE primarily enhanced cellular association via increased membrane partitioning, whereas incorporation of the corresponding sodium salt more effectively promoted mucus diffusion and epithelial permeation. These findings identify ionization state and formulation-dependent presentation as key design parameters for permeation-enhancing lipid-based drug delivery systems.
Indexed as
Identifiers
42690543What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.